Second, thanks to the Planning Committee and its Chair, Christine Bechtel. This workshop is being hosted by the IOM Roundtable on Value & Science-Driven Health Care in accordance with the National Academies’ rules and procedures. An independent Planning Committee, whose roster is in your folders, has organized the workshop with the support of the IOM staff, and they clearly have done a superb job; when you look at the list of Planning Committee members, you’ll know why this meeting turned out so well.
This brings me to the third group: the IOM staff. In particular, I would like to thank Leigh Stuckhardt, who has moved on to the Centers for Medicare & Medicaid Services; Julia Sanders, with the guiding hand of Dr. Claudia Grossmann, our Senior Program Officer coordinating the work; and Valerie Rohrbach, Barret Zimmermann, and Liz Johnston, who are here to facilitate the sessions. Please join me in thanking the Foundations, the Planning Committee, and the IOM staff for their work.
I would like to flag several additional items before I turn to stage-setting comments from Dominick, on behalf of the Moore Foundation, and from Christine, on behalf of the Planning Committee. First, each of you has received the briefing materials that were assembled by the IOM staff with recommendations from the Planning Committee. You also have received a folder that contains the agenda, participant list, one-page overview of the Roundtable’s work, and background material from the recent and important Health Affairs special issue on the topic of patient engagement, including both a table of contents from that issue and one key article. In addition to these materials, you will find a one-page summary that provides an overview of the strategy map for the work of the Roundtable. In particular, I draw your attention to this document because it includes a list of the ongoing projects that are under way in the various Collaboratives of the Roundtable, which underscores the essence of this meeting’s focus on action. What we want, in effect, is to emerge from the series of conversations with an action agenda that will allow us to be more focused as we work collaboratively across our various organizations to foster progress.
The Roundtable’s projects fall into three categories: value and improving the science of transparency; science and knowledge generation as real-time processes; and culture—strong public and patient engagement. The patient as a vital leader for each of these three aims—value, science, and decision making—and the focus on patients during this workshop are obviously clear. The conference sets the stage for success across all three domains, and we’re very hopeful about the outcomes of the discussions in providing guidance for the work ahead. Finally, when it comes to action, I would like to acknowledge those of you in the room who are participants in the session and who bring to this conversation the kind of commitment that is so important to the progress ahead.
The Planning Committee has worked very hard to ensure that this is truly a patient-centered set of discussions. Of course, each of us at one time or another has been or will be a patient and witness, and thus brings occasionally painful perspectives to these sorts of discussions. In addition to the primary cadre of attendees from the patient community, some of the agenda sessions are organized with patients as co-presenters, in order to ensure that the perspectives at every level are truly representative of the issues at hand. We also have here in the room individuals who have built, and are building, important organizational capacities to lead change and help foster follow-up to our discussions. Examples include Michael Barry, President of the Informed Medical Decisions Foundation; David Blumenthal, President of The Commonwealth Fund; Bob Kaplan, Director of the National Institutes of Health’s Office of Behavioral and Social Sciences Research; Lygeia Ricciardi, Head of Consumer Health at the Office of the